Images in Haematology
Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine
S. Bacchu, C. Fegan and J. Neal
p. 349–349
Improvement of fibrosis in a patient with chronic myeloproliferative disease
Andrew Retter, Deepti H. Radia, Claire N. Harrison
p. 350–350
Reviews
Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres
David J. Kuter, Barbara Bain, Ghulam Mufti, Adam Bagg and Robert P. Hasserjian
p. 351–362
Platelet glycoprotein VI-related clinical defects
Jane F. Arthur, Scott Dunkley and Robert K. Andrews
p. 363–372
Flexible and dynamic organization of bone marrow stromal compartment
Fernando Anjos-Afonso and Dominique Bonnet
p. 373–384
Haematological Malignancy
The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage
Rentian Feng, Ana Oton, Markus Y. Mapara, Gülsüm Anderson, Chandra Belani and Suzanne Lentzsch
p. 385–397
Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia
Kami Maddocks-Christianson, Susan L. Slager, Clive S. Zent, Megan Reinalda, Timothy G. Call, Thomas M. Habermann, Deborah A. Bowen, James D. Hoyer, Susan Schwager, Diane F. Jelinek, Neil E. Kay and Tait D. Shanafelt
p. 398–404
RUNX1 gene mutation in primary myelodysplastic syndrome – the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome
Chien-Yuan Chen, Liang-In Lin, Jih-Luh Tang, Bo-Sheng Ko, Woei Tsay, Wen-Chien Chou, Ming Yao, Shang-Ju Wu, Mei-Hsuan Tseng and Hwei-Fang Tien
p. 405–414
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides
Antonio Curti, Patrizia Tosi, Patrizia Comoli, Carolina Terragna, Elisa Ferri, Claudia Cellini, Massimo Massaia, Alessandra D’Addio, Valeria Giudice, Cristiana Di Bello, Michele Cavo, Roberto Conte, Gabriele Gugliotta, Michele Baccarani and Roberto M. Lemoli
p. 415–424
Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma
Owen A. O'Connor, Paul A. Hamlin, Carol Portlock, Craig H. Moskowitz, Ariela Noy, David J. Straus, Barbara MacGregor-Cortelli, Ellen Neylon,Debra Sarasohn, Otila Dumetrescu, Diane R. Mould, Martin Fleischer, Andrew D. Zelenetz, Frank Sirotnak and Steven Horwitz
p. 425–428
Thalidomide maintenance following high-dose therapy in multiple myeloma: a UK myeloma forum phase 2 study
Sylvia Feyler, Andy Rawstron, Graham Jackson, John A. Snowden, Kim Cocks and Roderick J. Johnson
p. 429–433
Stimulation of new bone formation by the proteasome inhibitor, bortezomib: implications for myeloma bone disease
Babatunde O. Oyajobi, I. Ross Garrett, Anjana Gupta, Alda Flores, Javier Esparza, Steve Muñoz, Ming Zhao and Gregory R. Mundy
p. 434–438
Prevalence of erythrocyte haemoglobin H inclusions in unselected patients with clonal myeloid disorders
David P. Steensma, Julie C. Porcher, Curtis A. Hanson, Cynthia L. Lathrop, James D. Hoyer, Terra A. Lasho, Ayalew Tefferi and Douglas R. Higgs
p. 439–442
Paediatric
Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma
Georg Mann, Andishe Attarbaschi, Birgit Burkhardt, Felix Niggli, Wolfram Klapper, Wolf-Dieter Ludwig, Martin Schrappe, Martin Zimmermann, Helmut Gadner and Alfred Reiter on behalf of The Berlin-Frankfurt-Münster Group
p. 443–449
High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia
Anja Troeger, Sonja Gudowius, Gabriele Escherich, Monique L. den Boer, Ludmila Glouchkova, Birgit Ackermann, Roland Meisel, Hans-Juergen Laws, Marketa Groeger, Ruediger Wessalowski, Reinhart Willers, Jochen Harbott, Rob Pieters, Ulrich Goebel, Gritta E. Janka-Schaub, Helmut Hanenberg and Dagmar Dilloo
p. 450–457
Transplantation
Association of autoimmune disease-related gene polymorphisms with chronic graft-versus-host disease
Masako Shimada, Makoto Onizuka, Shinichiro Machida, Rikio Suzuki, Minoru Kojima, Koichi Miyamura, Yoshihisa Kodera, Hidetoshi Inoko and Kiyoshi Ando
p. 458–463
Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults
Willem J. van Heeckeren, Laura R. Fanning, Howard J. Meyerson, Pingfu Fu, Hillard M. Lazarus, Brenda W. Cooper, William W. Tse, Tamila L. Kindwall-Keller, Jennifer Jaroscak, Marcie R. Finney, Robert M. Fox, Luis Solchaga, Margaret Forster, Richard J. Creger and Mary J. Laughlin
p. 464–474
Platelets, Haemostasis and Thrombosis
Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP
Ming Y. Shen, George Hsiao, Chang L. Liu, Tsorng H. Fong, Kuang H. Lin, Duen S. Chou and Joen R. Sheu
p. 475–485
Ciclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity
Spero R. Cataland, Ming Jin, Shili Lin, Melanie S. Kennedy, Eric H. Kraut, James N. George and Haifeng M. Wu
p. 486–493
Fibrinogen γ' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway
Rehana S. Lovely, Lynn K. Boshkov, Ulla M. Marzec, Stephen R. Hanson and David H. Farrell
p. 494–503
Correspondence
Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis
Catherine J. Wu, Mark Gladwin, John Tisdale, Matthew Hsieh, Terence Law, Melinda Biernacki, Shelby Rogers, Xunde Wang, Mark Walters, David Zahrieh, Joseph H. Antin, Jerome Ritz and Lakshamanan Krishnamurti
p. 504–507
Bi-clonal disease in patients with chronic lymphocytic leukaemia as detected by analysing IGHV mutation status
Mohammad Reza Sheikholeslami, Wanlong Ma, Jennifer Uyeji, Karl Tornyos, Lawrence Cone, Steven Mamus and Maher Albitar
p. 507–509
Combined factors V and VIII deficiency (F5F8D) in a Chinese family due to compound heterozygosity for nonsense mutations of the LMAN1 gene
Edmond S. K. Ma, Chris L. P. Wong, H. Y. Lam, Candy L. N. Wang and S. Y. Ma
p. 509–511
Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia vera
Linda M. Scott, Philip A. Beer, Anthony J. Bench, Wendy N. Erber and Anthony R. Green
p. 511–512
The contribution of α2-macroglobulin thrombin to the endogenous thrombin potential
H. C. Hemker, E. de Smedt, R. Al Dieri
p. 513–513 |
